Clinical Trial Update: NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

View source ↗

Summary

A clinical trial update from AstraZeneca reports monitoring improvement in Global Assessment of Functioning in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED